Cresco Labs Inc. (CRLBF), a cannabis products company, on Friday reported a wider net loss for the first quarter, reflecting decreased revenue and higher expenses.
For the three-month period to March 31, the company reported a net loss of $15.234 million, compared with a loss of $2.055 million in the same period last year. Loss before income taxes was $0.918 million as against a profit of $15.948 million a year ago.
Income from operations moved down to $13.589 million from last year's $29.163 million. Excluding items, EBITDA was $36.233 million, compared with $53.161 million a year ago.
Total operating expenses rose to $65.042 million from the prior year's $63.049 million. Total other expenses climbed to $14.507 million from $13.215 million in 2024.
Revenue was $165.757 million, down from $184.295 million in the previous year, reflecting the company's successful plan to reduce AR exposure by limiting sales to wholesale accounts with credit risk.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.